Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

HODGSON S.

Type

Journal article

Publisher

Elsevier

Publication Date

2020-07-20T00:00:00+00:00

Permalink Close